Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The use of biomarkers in the patient with heart failure.

Literature DB >> 23644993

The use of biomarkers in the patient with heart failure.

Punam Chowdhury¹, Devin Kehl, Rajiv Choudhary, Alan Maisel.

Abstract

Heart failure is a major burden to the health care system in terms of not only cost, but also morbidity and mortality. Appropriate use of biomarkers is critically important to allow rapid identification and optimal risk stratification and management of patients with both acute and chronic heart failure. This review will discuss the biomarkers that have the most diagnostic, prognostic, and therapeutic value in patients with heart failure. We will discuss established biomarkers such as natriuretic peptides as well as emerging biomarkers reflective of myocyte stress, myocyte injury, extracellular matrix injury, and both neurohormonal and cardio-renal physiology.

Entities: Disease Species

Mesh：

Substances：

Year: 2013 PMID： 23644993 DOI： 10.1007/s11886-013-0372-4

Source DB: PubMed Journal: Curr Cardiol Rep ISSN： 1523-3782 Impact factor: 2.931

103 in total

Review 1. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications.

Authors: Robb D Kociol; Peter S Pang; Mihai Gheorghiade; Gregg C Fonarow; Christopher M O'Connor; G Michael Felker
Journal: J Am Coll Cardiol Date: 2010-09-28 Impact factor: 24.094

2. Galectin-3, cardiac structure and function, and long-term mortality in patients with acutely decompensated heart failure.

Authors: Ravi V Shah; Annabel A Chen-Tournoux; Michael H Picard; Roland R J van Kimmenade; James L Januzzi
Journal: Eur J Heart Fail Date: 2010-06-05 Impact factor: 15.534

Review 3. Neurohormonal activation in congestive heart failure and the role of vasopressin.

Authors: Kanu Chatterjee
Journal: Am J Cardiol Date: 2005-05-02 Impact factor: 2.778

4. Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.

Authors: Kevin Damman; Dirk J Van Veldhuisen; Gerjan Navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan A Voors; Hans L Hillege
Journal: Heart Date: 2010-08 Impact factor: 5.994

5. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate.

Authors: Wolfgang Koenig; Dorothee Twardella; Hermann Brenner; Dietrich Rothenbacher
Journal: Clin Chem Date: 2004-11-24 Impact factor: 8.327

6. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.

Authors: Dominic Kelly; Iain B Squire; Sohail Q Khan; Paulene Quinn; Joachim Struck; Nils G Morgenthaler; Joan E Davies; Leong L Ng
Journal: J Card Fail Date: 2008-08-30 Impact factor: 5.712

7. The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.

Authors: Serge Masson; Roberto Latini; Emanuele Carbonieri; Luciano Moretti; Maria Grazia Rossi; Santo Ciricugno; Valentina Milani; Roberto Marchioli; Joachim Struck; Andreas Bergmann; Aldo P Maggioni; Gianni Tognoni; Luigi Tavazzi
Journal: Eur J Heart Fail Date: 2010-01-22 Impact factor: 15.534

8. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation.

Authors: M H M Hessel; D E Atsma; E J M van der Valk; W H Bax; M J Schalij; A van der Laarse
Journal: Pflugers Arch Date: 2007-10-02 Impact factor: 3.657

9. Usefulness of an elevated troponin-I in predicting clinical events in patients admitted with acute heart failure and acute coronary syndrome (from the RITZ-4 trial).

Authors: Wendy A Gattis; Christopher M O'Connor; Vic Hasselblad; Kirkwood F Adams; Isaac Kobrin; Mihai Gheorghiade
Journal: Am J Cardiol Date: 2004-06-01 Impact factor: 2.778

10. Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.

Authors: Rudolf A de Boer; Dirk J A Lok; Tiny Jaarsma; Peter van der Meer; Adriaan A Voors; Hans L Hillege; Dirk J van Veldhuisen
Journal: Ann Med Date: 2010-12-28 Impact factor: 4.709

12 in total

1. Changes of adrenomedullin and natriuretic peptides in patients with adrenal medullary hyperplasia prior to and following pharmacological therapy and adrenalectomy.

Authors: Pang-Hu Zhou; Lei Shi; Wei Hu; Xiao-Bin Zhang; Wei Wang; Li-Jun Zhang
Journal: Exp Ther Med Date: 2016-06-03 Impact factor: 2.447

2. Cardiac complications of chemotherapy: role of biomarkers.

Authors: Alessandro Colombo; Maria T Sandri; Michela Salvatici; Carlo M Cipolla; Daniela Cardinale
Journal: Curr Treat Options Cardiovasc Med Date: 2014-06

Review 3. Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors: Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal: Front Mol Biosci Date: 2019-10-18

Review 4. Clinical Significance of B-type Natriuretic Peptide in Heart Failure.

Authors: Byung-Su Yoo
Journal: J Lifestyle Med Date: 2014-03-31

5. Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseases.

Authors: Julie Chesné; Richard Danger; Karine Botturi; Martine Reynaud-Gaubert; Sacha Mussot; Marc Stern; Isabelle Danner-Boucher; Jean-François Mornex; Christophe Pison; Claire Dromer; Romain Kessler; Marcel Dahan; Olivier Brugière; Jérôme Le Pavec; Frédéric Perros; Marc Humbert; Carine Gomez; Sophie Brouard; Antoine Magnan
Journal: PLoS One Date: 2014-10-20 Impact factor: 3.240

6. Decreased Peripheral Mitochondrial DNA Copy Number is Associated with the Risk of Heart Failure and Long-term Outcomes.

Authors: Jin Huang; Lun Tan; Rufei Shen; Lina Zhang; Houjuan Zuo; Dao W Wang
Journal: Medicine (Baltimore) Date: 2016-04 Impact factor: 1.889